TEGSEDI
Google image searchProduct monograph
Active ingredient
inotersen (inotersen sodium), 284 MG/1.5 ML
DIN: 02481383
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE DOSE PREFILLED SYRINGE
Schedule: Prescription
Company: AKCEA THERAPEUTICS, INC.
Date: 07-JAN-2019
ATC:
- N07 — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD, )
- N07X — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD)
- N07XX — Other nervous system drugs (ATC, ATC/DDD)
- N07XX15 — INOTERSEN (ATC/DDD)
